Extra lymph node removal in left lung cancer surgery
Part of Cancer, Lungs & breathing clinical trials.
This trial compares two ways of doing lung cancer surgery for early-stage tumors in the left lung. Some participants will have more lymph nodes removed (station 4L) and others will not, to see if the extra removal helps prevent the cancer from coming back.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between the ages of 18 and 75.
- You have a single, solid lump (nodule) in your left lung that is confirmed to be cancer.
- Your cancer is early stage (stage 1), meaning the tumor is no larger than 4 cm and hasn't spread to lymph nodes or other organs.
- You are scheduled for surgery to remove the part of the lung with the tumor (segmentectomy or lobectomy) along with lymph nodes.
- You have not had lung surgery before, and you have not had radiation or chemotherapy for this cancer.
- You have no other cancer history.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares two types of lung cancer surgery for early-stage tumors: removing only the part of the lung with the tumor (segmentectomy) versus removing the entire lobe (lobectomy). It aims to see if the smaller surgery works just as well and might be easier to recover from.
This study tests a new way to decide which lymph nodes to remove during lung cancer surgery. The goal is to make surgery more precise and reduce side effects while still effectively removing cancer.
This study compares two types of lung surgery for early-stage lung cancer: removing only the tumor part (segmentectomy) versus removing a larger portion (lobectomy). The goal is to see if the less invasive surgery works just as well while preserving more healthy lung tissue.
This study compares two types of lung surgery for people with early-stage non-small cell lung cancer (a common type of lung cancer). One surgery removes a small part of the lung (segment), the other removes an entire lobe (a larger section of the lung). The goal is to see which approach offers better outcomes for tumors that are between 2 and 3 centimeters across and are solid (not just ground-glass).
This trial compares removing fewer lymph nodes during surgery for early-stage non-small cell lung cancer. It is for people with a small tumor (2 cm or less) that has both solid and ground-glass parts.
This study looks at whether removing lymph nodes from the opposite side of the chest during surgery can help people with advanced lung cancer that has spread to the lymph nodes in the middle of the chest. It may offer a more thorough treatment for patients who are healthy enough for surgery.
Hear when a new Non Small Cell Lung Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.